MASTROPASQUA, Mauro Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 4.813
AS - Asia 1.944
EU - Europa 1.217
SA - Sud America 596
AF - Africa 48
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.625
Nazione #
US - Stati Uniti d'America 4.738
SG - Singapore 974
BR - Brasile 539
HK - Hong Kong 345
CN - Cina 297
SE - Svezia 264
IT - Italia 209
RU - Federazione Russa 202
FR - Francia 116
DE - Germania 106
GB - Regno Unito 104
VN - Vietnam 88
IN - India 57
CA - Canada 42
UA - Ucraina 34
FI - Finlandia 31
AR - Argentina 26
BE - Belgio 26
AT - Austria 23
IQ - Iraq 19
MX - Messico 19
BD - Bangladesh 18
ID - Indonesia 18
TR - Turchia 17
PL - Polonia 16
ZA - Sudafrica 16
KR - Corea 15
ES - Italia 12
IE - Irlanda 12
JP - Giappone 11
IR - Iran 9
NP - Nepal 9
UZ - Uzbekistan 9
VE - Venezuela 9
NL - Olanda 8
PK - Pakistan 8
SA - Arabia Saudita 8
EC - Ecuador 7
RO - Romania 7
CL - Cile 6
AE - Emirati Arabi Uniti 5
CI - Costa d'Avorio 5
HR - Croazia 5
JO - Giordania 5
LT - Lituania 5
AU - Australia 4
BG - Bulgaria 4
CZ - Repubblica Ceca 4
EG - Egitto 4
KE - Kenya 4
MA - Marocco 4
MY - Malesia 4
PH - Filippine 4
RS - Serbia 4
AL - Albania 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
EE - Estonia 3
HU - Ungheria 3
IL - Israele 3
KZ - Kazakistan 3
PE - Perù 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
BN - Brunei Darussalam 2
CO - Colombia 2
ET - Etiopia 2
GE - Georgia 2
JM - Giamaica 2
KW - Kuwait 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
OM - Oman 2
PY - Paraguay 2
QA - Qatar 2
AM - Armenia 1
AZ - Azerbaigian 1
BB - Barbados 1
BJ - Benin 1
BO - Bolivia 1
BS - Bahamas 1
CH - Svizzera 1
CM - Camerun 1
CR - Costa Rica 1
CY - Cipro 1
GN - Guinea 1
GR - Grecia 1
GT - Guatemala 1
IS - Islanda 1
LB - Libano 1
LC - Santa Lucia 1
LI - Liechtenstein 1
LK - Sri Lanka 1
MK - Macedonia 1
MN - Mongolia 1
MT - Malta 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
Totale 8.614
Città #
Chandler 579
Fairfield 571
Ashburn 467
Singapore 434
Hong Kong 344
Woodbridge 277
Houston 269
Seattle 248
Wilmington 221
Nyköping 205
Cambridge 198
Ann Arbor 134
Lawrence 112
Beijing 104
Roxbury 91
Los Angeles 80
New York 73
Des Moines 69
Dallas 63
Jacksonville 56
Paris 51
The Dalles 50
Columbus 46
Bari 45
Santa Clara 41
San Diego 40
São Paulo 39
Council Bluffs 36
Buffalo 32
Princeton 32
Ho Chi Minh City 30
London 30
Munich 29
Nanjing 28
Brussels 26
Cressa 24
Nuremberg 24
Pune 24
Moscow 22
Falls Church 21
Hanoi 21
Belo Horizonte 19
Chicago 18
Inglewood 18
Brooklyn 17
Frankfurt am Main 17
Rio de Janeiro 17
Boardman 15
Dearborn 14
Washington 14
Milan 13
San Mateo 13
Toronto 13
Brasília 12
Dublin 12
Vienna 12
Warsaw 12
Atlanta 11
Boston 11
Edinburgh 11
Tokyo 11
Denver 10
Jakarta 10
Ardabil 9
Chennai 9
Curitiba 9
Leawood 9
Montreal 9
Seoul 9
Stockholm 9
Campinas 8
San Francisco 8
Tashkent 8
Amsterdam 7
Augusta 7
Guangzhou 7
Hebei 7
Hounslow 7
Istanbul 7
Recife 7
Baghdad 6
Helsinki 6
Johannesburg 6
Kathmandu 6
Phoenix 6
Porto Alegre 6
Ribeirão Preto 6
Wuhan 6
Abidjan 5
Amman 5
Changsha 5
Cuiabá 5
Düsseldorf 5
Fucecchio 5
Grafing 5
Guarulhos 5
Hefei 5
Kilburn 5
Madrid 5
Manchester 5
Totale 5.830
Nome #
How reliable is Ki-67 immunohistochemistry in grade 2 breast carcinomas? A QA study of the Swiss working group of breast- and gynecopathologists 199
Analytical validation of a standardized scoring protocol for Ki67: Phase 3 of an international multicenter collaboration 198
A risk score based on histopathological features predicts higher risk of distant recurrence in premenopausal patients with lymph node-negative endocrine-responsive breast cancer 163
Vascular density and inflammatory infiltrate in primary oral squamous cell carcinoma and after allogeneic hematopoietic stem cell transplantation 159
Inflammatory cells infiltrate and angiogenesis in locally advanced and metastatic cholangiocarcinoma 149
Adenomyoepithelioma 135
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial 128
A new technique for foetal brain fixation and extraction 124
Tumore a Cellule del Sertoli a Grandi Cellule Calcificante (TCSGCC) ad evoluzione maligna. Studio di un caso. 115
Angiosarcoma and atypical vascular lesions of the breast: diagnostic and prognostic role of MYC gene amplification and protein expression 102
Abstract S4-6: An international Ki67 reproducibility study 96
A nomogram based on the expression of Ki-67, steroid hormone receptors status and number of chemotherapy courses to predict pathological complete remission after preoperative chemotherapy for breast cancer 96
BETA-GALACTOSYLCERAMIDASE PROMOTES MELANOMA GROWTH VIA MODULATION OF CERAMIDE METABOLISM 96
Abstract P5-02-01: Analytical validation and prognostic potential of an automated digital scoring protocol for Ki67: An International Ki67 Working Group study 95
An international study to increase concordance in Ki67 scoring 94
Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer. Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy 93
Microscopic esophagitis and Barrett in endoscopy-negative gastroesophageal reflux disease (GERD) 93
Accelerated partial breast irradiation with intraoperative electrons: Using GEC-ESTRO recommendations as guidance for patient selection 93
Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial 91
Pathological complete response after preoperative systemic therapy and outcome: Relevance of clinical and biologic baseline features 91
Paget's disease as a local recurrence after nipple-sparing mastectomy: Clinical presentation, treatment, outcome, and risk factor analysis 90
Angiomixoma aggressivo dello scroto. Studio di un caso 89
null 88
Abstract P5-07-02: Systematic analysis and modulation of Ki67 interobserver variance in 9069 patients from three clinical trials – How much pathologist concordance is needed for meaningful biomarker results? 88
Ectopic breast tissue as a possible cause of false-positive axillary sentinel lymph node biopsies 87
Testicular Modification Induced by Low Alcohol Intake in Rat. Morphometric Investigations and bcl-2 Oncogene Expression 84
Analytical validation of a standardized scoring protocol for Ki67 assessed on breast excision whole sections: An international multicenter collaboration 83
Peri-Prostatic Epidermal Inclusion Cyst: A Case Report 83
Correlation of size and focality with prognosis in small breast carcinoma: a single institution case series 83
Analytical validation of a standardized scoring protocol for Ki67: Phase-3 of an international multicenter collaboration 82
Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer 81
Mechanical characterization of human urethra 80
Mammary stereotaxic core-biopsy by Mammotome: an alternative to frozen section examination 79
Survival outcomes in breast cancer patients with low estrogen/progesterone receptor expression 79
Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer 79
Sensitivity and Detection Rate of a 12-Core Trans-Perineal Prostate Biopsy: Preliminary Report 79
Analytical validation of a standardised scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicentre collaboration 79
An international ki67 reproducibility study 79
Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial 78
Traditional molecular markers and response to adjuvant endocrine or trastuzumab-based therapies 77
How do the ASTRO consensus statement guidelines for the application of accelerated partial breast irradiation fit intraoperative radiotherapy? A retrospective analysis of patients treated at the European Institute of Oncology 77
Intra-Cystic (In Situ) Mucoepidermoid Carcinoma: A Clinico-Pathological Study of 14 Cases 76
Abstract P1-15-06: Lobular histology and partial breast irradiation: To what extent is it a cautionary parameter? 75
Immunoreactivity for c-kit and p63 as an adjunct in the diagnosis of adenoid cystic carcinoma of the breast 75
Regulation of mRNA and protein levels of beta 1 integrin variants in human prostate carcinoma 74
Breast cancer subtypes and outcome after local and regional relapse 74
Prognostic value of Ki-67 labeling index in patients with node-negative, triple-negative breast cancer 74
Basaloid cell carcinoma of the prostate. Case report and review of the literature 74
Final 10-year results of the Breast International Group 2-98 phase III trial and the role of Ki67 in predicting benefit of adjuvant docetaxel in patients with oestrogen receptor positive breast cancer 73
Primary and secondary angiosarcomas of the breast: A single institution experience 73
Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes 72
High Ki67 predicts unfavourable outcomes in early breast cancer patients with a clinically clear axilla who do not receive axillary dissection or axillary radiotherapy 72
Malignant Large Cell Calcifying Sertoli Cell Tumor of the Testis (LCCSCTT). Report of a case in an elderly man and review of the literature 71
Positive axillary sentinel lymph node: Is axillary dissection always necessary? 71
Clinicopathological and immunohistochemical study of 30 cases of post-radiation atypical vascular lesion of the breast 71
Outcome of special types of luminal breast cancer 71
Microbiopsia mammaria stereotassica. 69
Progesterone receptor loss identifies luminal B breast cancer subgroups at higher risk of relapse 69
Pathologic examination of the axillary sentinel lymph nodes in patients with early-stage breast carcinoma: Current and resolving controversies on the basis of the European Institute of Oncology experience 68
Clinical and pathological assessment of high-risk ductal and lobular breast lesions: What surgeons must know 68
What can the pathologist offer for optimal treatment choice? 68
Heterogeneity of triple-negative breast cancer: Histologic subtyping to inform the outcome 67
Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes 67
Mesotelioma multicistico benigno del pericardio. Descrizione di un caso 66
Risk of locoregional recurrence in patients with false-negative frozen section or close margins of retroareolar specimen in nipple-sparing mastectomy 64
HER2-negative (1+) breast cancer with unfavorable prognostic features: To FISH or not to FISH? 64
Breast cancer subtypes and outcome after local and regional relapse 63
Prognostic significance of Ki-67 in node-negative (pN0), triple-negative (TN) breast cancer (BC) 63
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): A phase 3 randomised controlled trial 63
Wireless ultrasound-guided vacuum-assisted breast biopsy: Experience in clinical practice at European Institute of Oncology 63
Benign multicystic mesothelioma of the pericardium (BMMP). A case report 62
Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy 62
Atypical Ductal Hyperplasia after Vacuum-Assisted Breast Biopsy: Can We Reduce the Upgrade to Breast Cancer to an Acceptable Rate? 62
p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer 61
Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapy 61
Metastatic tumors of the oro-facial tissues: Clear cell renal cell carcinoma. A clinico-pathological study of seven cases 61
Outcome and medial presentation of breast cancer: European Institute of Oncology experience 60
Immunohistochemically defined subtypes and outcome in occult breast carcinoma with axillary presentation 60
Osteoclast-like stromal giant cells in invasive ductal breast cancer: A case series 60
Studio delle regioni organizzatrici argirofile del nucleolo (AgNORs) nelle neoformazioni colo-rettali quale indice di malignità biologica. [Argyrophilic nucleolar organizer regions (AgNORs) as malignancy biomarkers in colorectal neoplasms]. 59
null 59
The prognostic role of high Ki-67 in early breast cancer patients who do not receive axillary dissection or axillary radiotherapy 59
Calcified metastatic mediastinal lymph nodes from mucinous breast adenocarcinoma 59
Male breast cancer 59
Complete removal of the lesion as a guidance in the management of patients with breast ductal carcinoma in Situ 59
Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes 58
Comparison of Treatment Outcome Between Invasive Lobular and Ductal Carcinomas in Patients Receiving Partial Breast Irradiation With Intraoperative Electrons 58
Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapy 58
null 57
Evaluation of computer-aided diagnosis in breast ultrasonography: Improvement in diagnostic performance of inexperienced radiologists 57
A New Possible Cut-Off of Cytokeratin 19 mRNA Copy Number by OSNA in the Sentinel Node of Breast Cancer Patients to Avoid Unnecessary Axillary Dissection: A 10-Year Experience in a Tertiary Breast Unit 56
Central Review of ER, PgR and HER2 in BIG 1-98 Evaluating Letrozole vs. Letrozole Followed by Tamoxifen vs. Tamoxifen Followed by Letrozole as Adjuvant Endocrine Therapy for Postmenopausal Women with Hormone Receptor-Positive Breast Cancer 56
Breast cancer pathology 56
Robotic vs open prostatectomy in a laparoscopically naive centre: A matched-pair analysis 55
Atypical vascular lesions after radiation therapy for breast cancer: A clinicopathologic study and outcomes of 24 cases 55
COVID-19 And Breast Fine Needle Aspiration Cytology Method: What Should We Change? 55
β3 adrenergic receptor as potential therapeutic target in ADPKD 54
Advances and controversies in management of breast ductal carcinoma in situ (DCIS) 53
Occasional finding of a carcinoid in a vermiform appendix-like structure inside a mature cystic teratoma of the ovary 52
Primary Breast Extranodal Marginal Zone Lymphoma in Primary Sjögren Syndrome: Case Presentation and Relevant Literature 52
Totale 7.887
Categoria #
all - tutte 49.930
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.930


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021656 0 0 0 0 0 30 59 149 45 158 82 133
2021/2022692 36 25 1 19 55 110 13 36 40 95 52 210
2022/20231.466 154 149 91 147 105 190 50 234 207 20 95 24
2023/2024525 41 84 34 24 51 121 21 42 3 14 35 55
2024/20251.998 17 34 159 90 106 214 172 139 136 139 285 507
2025/20261.819 585 207 172 292 493 70 0 0 0 0 0 0
Totale 9.043